- Home
- CMBM vs HOTH Comparison
CMBM vs HOTH Comparison
Compare CMBM & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- HOTH
- Stock Information
- Founded
- CMBM 2011
- HOTH 2017
- Country
- CMBM United States
- HOTH United States
- Employees
- CMBM 625
- HOTH N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- HOTH Health Care
- Exchange
- CMBM Nasdaq
- HOTH Nasdaq
- Market Cap
- CMBM 9.6M
- HOTH 8.3M
- IPO Year
- CMBM 2019
- HOTH 2019
- Fundamental
- Price
- CMBM $0.40
- HOTH $1.14
- Analyst Decision
- CMBM Strong Buy
- HOTH Strong Buy
- Analyst Count
- CMBM 2
- HOTH 3
- Target Price
- CMBM $5.50
- HOTH $4.00
- AVG Volume (30 Days)
- CMBM 5.2M
- HOTH 3.0M
- Earning Date
- CMBM 08-07-2025
- HOTH 05-12-2025
- Dividend Yield
- CMBM N/A
- HOTH N/A
- EPS Growth
- CMBM N/A
- HOTH N/A
- EPS
- CMBM N/A
- HOTH N/A
- Revenue
- CMBM $172,215,000.00
- HOTH N/A
- Revenue This Year
- CMBM N/A
- HOTH N/A
- Revenue Next Year
- CMBM $17.87
- HOTH N/A
- P/E Ratio
- CMBM N/A
- HOTH N/A
- Revenue Growth
- CMBM N/A
- HOTH N/A
- 52 Week Low
- CMBM $0.23
- HOTH $0.58
- 52 Week High
- CMBM $2.97
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- CMBM 54.18
- HOTH 51.11
- Support Level
- CMBM $0.38
- HOTH $1.15
- Resistance Level
- CMBM $0.41
- HOTH $1.34
- Average True Range (ATR)
- CMBM 0.04
- HOTH 0.13
- MACD
- CMBM 0.01
- HOTH -0.02
- Stochastic Oscillator
- CMBM 90.38
- HOTH 19.44
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.